ORTHOPEDIATRICS CORP Quarterly Nonoperating Income (Expense) in USD from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Orthopediatrics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2016 to Q3 2024.
  • Orthopediatrics Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$3.57M, a 566% decline year-over-year.
  • Orthopediatrics Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$3.4M, a 173% decline year-over-year.
  • Orthopediatrics Corp annual Nonoperating Income (Expense) for 2023 was $5.44M, a 74.9% decline from 2022.
  • Orthopediatrics Corp annual Nonoperating Income (Expense) for 2022 was $21.7M, a 3314% increase from 2021.
  • Orthopediatrics Corp annual Nonoperating Income (Expense) for 2021 was $636K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.4M -$3.57M -$4.34M -566% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $935K -$381K -$2.68M -117% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $3.62M -$613K -$1.82M -151% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.44M $1.16M +$750K +182% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $4.69M $766K -$20.6M -96.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $25.3M $2.3M -$672K -22.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $26M $1.21M +$4.24M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $21.7M $413K -$4.98M -92.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $26.7M $21.4M +$20.2M +1749% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $6.49M $2.97M +$4.17M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $2.32M -$3.03M +$1.69M +35.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $636K $5.4M +$7.39M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-08
Q3 2021 -$6.75M $1.16M +$3.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$9.95M -$1.2M +$1.23M +50.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$11.2M -$4.72M -$4.27M -953% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$6.91M -$1.99M -$695K -53.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$6.22M -$2.04M -$703K -52.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$5.51M -$2.43M -$1.76M -263% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$3.75M -$448K -$145K -47.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.61M -$1.3M -$696K -116% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 -$2.91M -$1.34M -$645K -93.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$2.27M -$669K -$97K -17% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$2.17M -$303K +$302K +49.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$2.47M -$602K +$1.22M +66.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 -$3.69M -$693K +$88K +11.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$3.78M -$572K -$1.16M -197% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$2.62M -$605K -$157K -35% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$2.46M -$1.82M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$781K -$459K -143% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $589K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$448K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 -$322K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.